Therapeutic efficacy of anti‐MMP9 antibody in combination with nab‐paclitaxel‐based chemotherapy in pre‐clinical models of pancreatic cancer-Reference-Cited by-同舟云学术

Therapeutic efficacy of anti‐MMP9 antibody in combination with nab‐paclitaxel‐based chemotherapy in pre‐clinical models of pancreatic cancer

Author:

Awasthi Niranjan¹²^ORCID,Mikels‐Vigdal Amanda J.³,Stefanutti Erin³,Schwarz Margaret A.²⁴,Monahan Sheena¹,Smith Victoria³,Schwarz Roderich E.¹²^ORCID

Affiliation:

1. Department of Surgery Indiana University School of Medicine South Bend Indiana

2. Harper Cancer Research InstituteUniversity of Notre Dame South Bend Indiana

3. Gilead Sciences Inc. Foster City California

4. Department of Pediatrics Indiana University School of Medicine South Bend Indiana

Funder

Indiana University

Gilead Sciences

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

Reference41 articles.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Targeting short-lived immunosuppressive myeloid cells for PDAC therapy;Immune Landscape of Pancreatic Cancer Development and Drug Resistance;2024